Joaquim Bellmunt Molins MD, PhD

Dr. Joaquim Bellmunt graduated in Medicine and Surgery from the Autonomous University of Barcelona in 1982 and obtained his Ph.D. cum laude in 1989 from the same university. After undergoing the residency in Medical Oncology at the Hebron Valley University Hospital in Barcelona, he completed his studies obtaining the European Certificate in Medical Oncology in London in 1989 and rotating at the Clinical Immunology Service, Division of Medical Oncology and Department Immunopathology at Memorial Sloan-Kettering Cancer Center in New York in 1987 and 1989. He joined the Department of Medical Oncology, Hebron Valley University Hospital taking over the Uro-oncology Clinic.

His areas of interest in genitourinary oncology include the development of drugs directed to novel therapeutic targets and early clinical and translational research in the field of immunotherapy and factor receptors and angiogenesis. He directs multicenter international trials of immunotherapy in the treatment of prostate, kidney and bladder cancer. He coordinated the Intergroup Study in Advanced Transitional Cell Carcinoma (EORTC 30987). He is involved in the clinical development of new agents and combinations and is a member of the advisory board of several pharmaceutical companies.